Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
30.24
-0.07 (-0.23%)
Apr 30, 2026, 3:04 PM CST
SHE:002864 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,230 | - | 1,169 | 1,102 | 823.44 | 419.3 |
Cash & Short-Term Investments | 1,230 | - | 1,169 | 1,102 | 823.44 | 419.3 |
Cash Growth | 5.53% | - | 6.11% | 33.83% | 96.38% | 9.77% |
Accounts Receivable | 531.21 | - | 494.59 | 476.42 | 538.41 | 446.38 |
Other Receivables | 7.98 | - | 2.12 | 3.07 | 2.13 | 2.55 |
Receivables | 539.19 | - | 496.71 | 479.49 | 540.54 | 448.93 |
Inventory | 117.34 | - | 95.58 | 77.63 | 94.63 | 66.77 |
Other Current Assets | 31.43 | - | 9.86 | 18.67 | 23.33 | 21.45 |
Total Current Assets | 1,918 | - | 1,772 | 1,678 | 1,482 | 956.45 |
Property, Plant & Equipment | 431.24 | - | 438.21 | 371.7 | 353.74 | 275.04 |
Long-Term Investments | 10.02 | - | 10.21 | 9.71 | 9.89 | - |
Other Intangible Assets | 49.75 | - | 51.35 | 52.76 | 54.9 | 56.33 |
Long-Term Deferred Tax Assets | 12.03 | - | 4.89 | 7.22 | 16.63 | 20.2 |
Long-Term Deferred Charges | 4.25 | - | 3.12 | 2.87 | 1.31 | 0.02 |
Other Long-Term Assets | 7.03 | - | 0.71 | 2.96 | 12.36 | 22.13 |
Total Assets | 2,432 | - | 2,280 | 2,125 | 1,931 | 1,330 |
Accounts Payable | 132.64 | - | 107.92 | 91.43 | 121.67 | 66.01 |
Accrued Expenses | 12.38 | - | 187.96 | 181.38 | 215.43 | 176.72 |
Short-Term Debt | 50 | - | 50 | 100 | 150.46 | 87.2 |
Current Portion of Long-Term Debt | 0.84 | - | 1 | - | 247.62 | 13 |
Current Portion of Leases | - | - | 0.31 | 0.39 | 1.41 | 2.03 |
Current Income Taxes Payable | 24.77 | - | 8.66 | 9.11 | 14.73 | 17.21 |
Current Unearned Revenue | 8.07 | - | 3.68 | 5.53 | 13.26 | 4.7 |
Other Current Liabilities | 281.24 | - | 86.59 | 92.57 | 138.11 | 70.69 |
Total Current Liabilities | 509.95 | - | 446.11 | 480.41 | 902.68 | 437.55 |
Long-Term Debt | 100 | - | 98.5 | - | 27.35 | 40.35 |
Long-Term Leases | 1.51 | - | 2.33 | 2.11 | 0.33 | 1.32 |
Long-Term Unearned Revenue | 110.18 | - | 95.9 | 91.25 | 52.83 | 41.4 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 2.35 |
Total Liabilities | 721.64 | - | 642.84 | 573.76 | 983.18 | 522.97 |
Common Stock | 106.28 | - | 106.28 | 106.28 | 86.71 | 86.67 |
Additional Paid-In Capital | 813.9 | - | 816.64 | 817.78 | 259.43 | 271.67 |
Retained Earnings | 813.49 | - | 737.25 | 640.06 | 548.96 | 463.19 |
Treasury Stock | -25.08 | - | -24.95 | -15.07 | -15.07 | -30.15 |
Comprehensive Income & Other | - | - | - | - | 49.62 | - |
Total Common Equity | 1,709 | - | 1,635 | 1,549 | 929.65 | 791.38 |
Minority Interest | 2.17 | - | 1.97 | 2.21 | 17.95 | 15.82 |
Shareholders' Equity | 1,711 | - | 1,637 | 1,551 | 947.6 | 807.21 |
Total Liabilities & Equity | 2,432 | - | 2,280 | 2,125 | 1,931 | 1,330 |
Total Debt | 152.35 | - | 152.14 | 102.49 | 427.16 | 143.9 |
Net Cash (Debt) | 1,078 | - | 1,017 | 999.52 | 396.28 | 275.41 |
Net Cash Growth | 6.24% | - | 1.77% | 152.22% | 43.89% | -1.78% |
Net Cash Per Share | 10.31 | - | 9.73 | 10.23 | 4.58 | 3.22 |
Filing Date Shares Outstanding | 103.62 | 101.64 | 105.91 | 105.15 | 95.8 | 85.54 |
Total Common Shares Outstanding | 103.62 | 101.64 | 105.91 | 105.15 | 85.59 | 85.54 |
Working Capital | 1,408 | - | 1,325 | 1,197 | 579.27 | 518.89 |
Book Value Per Share | 16.49 | - | 15.44 | 14.73 | 10.86 | 9.25 |
Tangible Book Value | 1,659 | - | 1,584 | 1,496 | 874.75 | 735.05 |
Tangible Book Value Per Share | 16.01 | - | 14.96 | 14.23 | 10.22 | 8.59 |
Buildings | - | - | 398.37 | 331.9 | 329.36 | 152.82 |
Machinery | - | - | 144.4 | 134.72 | 125.41 | 60.38 |
Construction In Progress | - | - | 56.05 | 29.31 | 3.85 | 152.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.